Intelligence Platform

Patents

Browse 24 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12226488

Nitroreductase-releasable pro-drugs and methods for using the same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11975066

Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses there

SAB Biotherapeutics, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11932726

Method of making releasable polymeric reagents

Nektar Therapeutics · Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11865122

Estrogen therapy for brain gray matter atrophy and associated disability

The Regents of the University of California · Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10927362

Processable single chain molecules and polypeptides made using same

BIOVERATIV THERAPEUTICS INC. · Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10821117

Estrogen therapy for brain gray matter atrophy and associated disability

The Regents of the University of California · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143751

Photodynamic therapy, formulation usable for this purpose, and method for the production a

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10029017

Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug

The Regents of the University of California · Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856468

Processable single chain molecules and polypeptides made using same

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775900

Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method f

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9662322

Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients wit

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9658230

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA o

Ludwig-Maximilians-Universitat Munchen · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629932

Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method f

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493544

Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

Nektar Therapeutics · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9308176

Less abusable pharmaceutical preparations

Supernus Pharmaceuticals, Inc. · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260511

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA o

Julius-Maximilians-Universitat Wurzburg · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609102

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA o

Julius-Maximilians-Universitaet · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575102

Conjugates having a releasable linkage

Nektar Therapeutics · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536148

Disabling autophagy as a treatment for lysosomal storage diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507653

Factor IX moiety-polymer conjugates having a releasable linkage

Nektar Therapeutics · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349800

Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

Nektar Therapeutics · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133865

von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

Nektar Therapeutics · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060686

Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae

The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6787571

Anti-inflammatory compounds derived from Pseudopterorgorgia elisabethae

The Regents of the University of California · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired